February 11, 2021

Citywide Serosurveillance of the Initial SARS-CoV-2 Outbreak in San Francisco

Category: Article Summary

Topic: Testing and Treatment

Keywords (Tags): immunity, testing

[Pre-print, not peer reviewed] SARS-CoV-2 serosurveillance using remnant samples from routine blood draws in two major hospital networks in San Francisco estimated a seroprevalence of 4.2% in the period between March and June 2020.  Seroprevalence was higher among those who were uninsured; individuals identifying as Hispanic, Black, or African; males; and individuals who experience homelessness. Seroprevalence estimates were comparable to previous community-based surveys.  

Routledge et al. (Feb 4, 2021). Citywide Serosurveillance of the Initial SARS-CoV-2 Outbreak in San Francisco. Pre-print downloaded Feb 11 from  https://doi.org/10.21203/rs.3.rs-180966/v1